In the rapidly evolving landscape of aesthetic medicine, the demand for non-surgical facial rejuvenation has reached unprecedented heights. With over 5.3 million procedures performed in 2024 alone, hyaluronic acid (HA) dermal fillers stand as the gold standard for restoring lost facial volume and mitigating the signs of aging. However, for years, the industry has relied heavily on anecdotal evidence and subjective patient assessments to gauge success.
A landmark study published in the October issue of Plastic and Reconstructive Surgery—the official medical journal of the American Society of Plastic Surgeons (ASPS)—is changing that narrative. By integrating cutting-edge 3D digital scanning technology with rigorous patient-reported outcomes, researchers have provided the first objective, long-term roadmap of how these fillers behave beneath the skin, offering both practitioners and patients a new level of clinical transparency.
Main Facts: Quantifying the “Fill”
The study, led by senior author Dr. Ivona Percec, a prominent plastic surgeon and researcher at the University of Pennsylvania, sought to bridge the gap between "what we see" and "what we measure." While previous literature consistently praised the aesthetic improvements offered by HA fillers, there remained a dearth of granular data regarding how these products settle, migrate, or diminish over time.
To address this, the research team recruited 101 women, aged 40 to 65, to undergo standardized HA filler treatments. The core of the study utilized the Vectra M3 imaging system—a sophisticated 3D scanning technology—to capture precise volumetric changes in eight distinct facial zones. By analyzing the "Tissue Displacement Factor" (TDF) and "Effective Volume" (EV), the researchers were able to track the material’s behavior from the moment of injection through a 12-week follow-up period.
The findings reveal that the "immediate" look of a filler treatment is often a misleading indicator of the final result. While the initial scan showed an immediate volume increase ranging from 56% to 125%, this figure represents a combination of the filler material itself and the natural, transient inflammatory response (swelling) of the skin. As that inflammation subsides, the true clinical volume begins to emerge.
A Chronology of Volumetric Change
Understanding the lifecycle of an HA filler is crucial for managing patient expectations. The study highlights a distinct timeline for how these substances integrate into facial tissue:
The Immediate Aftermath (0–48 Hours)
Post-injection, the face exhibits maximum volume due to the mechanical presence of the filler and the body’s acute inflammatory response. During this window, patients often experience "over-filling" effects, which are purely temporary.
The Stabilization Phase (Two Weeks)
By the two-week mark, the acute swelling has largely resolved. This is the period where the "Effective Volume" (EV) becomes apparent. The study found that by this stage, the EV was approximately 90% for the mid-face and lower-face, and 70% for the lips. This two-week milestone is identified by the authors as the most accurate window for assessing the "final" clinical result of the procedure.
The Maintenance Phase (12 Weeks)
At the 12-week follow-up, the study observed a natural settling of the filler. Total facial volume maintenance sat at approximately 66%. However, this percentage varied significantly by location:
- Mid-face (Cheeks): Showed the highest retention, at 79%.
- Perioral region (Marionette lines): Showed a retention of 63%.
- Lips: Exhibited the lowest volume retention at 37%, likely due to the high degree of mechanical animation in the mouth area and the use of smaller-particle, more pliable filler formulations designed specifically for the delicate lip tissue.
Supporting Data: The Patient Perspective
Objective data is only one half of the clinical equation. To understand the psychological and social impact of these treatments, the researchers utilized the FACE-Q questionnaire—a validated, patient-reported outcome measure.
The results were overwhelmingly positive. Participants reported not only a significant improvement in their physical appearance but also quantifiable gains in psychological well-being and social confidence. This confirms that even as the filler settles and total volume decreases from the initial "pumped" state, the patient’s perceived satisfaction remains high.
The data suggests a disconnect between raw volume and patient perception: even as the physical volume of the filler diminished toward the 12-week mark, patients continued to report high levels of satisfaction. This indicates that the "ideal" result is not necessarily the highest volume, but rather the most natural-looking restoration of facial contours.
Official Responses: Clinical Implications
Dr. Ivona Percec emphasizes that the study’s findings are intended to refine how surgeons approach consultations. "Our study combines objective measurements of volumetric effects with patient satisfaction and other subjective outcomes to provide a deeper understanding of the immediate and long-term course of improvement," says Dr. Percec.
The research team points to several patient-specific variables that complicate the "one-size-fits-all" approach to filler dosing. Factors such as a patient’s age, their history of smoking, and their body mass index (BMI) play a measurable role in how long the filler is maintained.
"These and other patient-specific variables contribute significantly to outcomes of HA gel injections, requiring individual assessment," Dr. Percec notes. The study concludes that practitioners should be using these volumetric metrics—specifically TDF and EV—as a standard part of patient counseling. By explaining to patients that the "immediate" post-treatment look will evolve as the body integrates the product, surgeons can better align patient expectations with clinical reality, ultimately reducing the anxiety associated with the post-treatment healing process.
Implications for the Future of Aesthetic Medicine
This study marks a paradigm shift in how aesthetic procedures are validated. By moving away from purely aesthetic, subjective "before-and-after" photos and toward high-fidelity, volumetric 3D analysis, the field is stepping into an era of evidence-based cosmetic surgery.
Precision Medicine in Aesthetics
The observation that volume retention varies wildly between the cheeks and the lips suggests that the physical properties of different HA formulations must be matched more precisely to the specific facial area. The "smaller-particle" products used in the lips, while ideal for creating a natural, soft feel, clearly do not hold their volume as long as the more robust products used in the mid-face. This information allows for more strategic treatment planning.
Addressing the "Over-Filling" Trap
One of the most important takeaways for the public is the realization that immediate, post-injection volume is not the permanent result. By educating patients that the two-week mark is the true indicator of their results, surgeons can discourage the "more is better" mentality that often leads to the over-filled, "pillowed" look often seen in celebrities.
A Foundation for Future Research
The methodology established by the University of Pennsylvania team sets a standard for future clinical trials. As the global filler market continues to grow, the need for longitudinal studies—tracking outcomes at six months, one year, and beyond—is critical. This study provides the baseline, suggesting that while fillers are highly effective, they are also dynamic, interacting with the aging process and individual lifestyle factors in complex ways.
Conclusion
The intersection of 3D technology and patient-reported outcomes provides a comprehensive picture of what it means to "restore volume" in the aging face. HA fillers, when applied with an understanding of their volumetric lifecycle, are powerful tools for rejuvenation. By embracing the data provided by Dr. Percec and her colleagues, the medical community can move toward a more predictable, satisfying, and patient-centered future in plastic surgery. As the science continues to evolve, the goal remains the same: helping patients achieve a refreshed, natural look that feels as good as it looks.
For more information on the research, the study "A Large Prospective Volumetric and Patient-Reported Outcome Analysis of Hyaluronic Acid Facial Fillers" can be accessed via the Plastic and Reconstructive Surgery journal (doi: 10.1097/PRS.0000000000012135).
About Wolters Kluwer
Wolters Kluwer (EURONEXT: WKL) is a global leader in professional information, software solutions, and services for the healthcare, tax and accounting, financial and corporate compliance, legal and regulatory, and corporate performance and ESG sectors. Headquartered in the Netherlands, the firm serves customers in over 180 countries, leveraging deep domain knowledge to assist professionals in making critical, data-backed decisions. With a commitment to innovation and specialized technology, Wolters Kluwer remains at the forefront of providing the data that powers modern medical journals and professional research worldwide.
About the Author
